| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 21,082 | 24,948 | 24,538 | 28,402 | | Selling General and Administrative | 5,573 | 5,050 | 4,603 | 5,608 | | Non Recurring |
-
|
-
| 1,141 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (26,655) | (29,998) | (30,282) | (34,010) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 48 | 159 | 347 | 586 | | Earnings Before Interest And Taxes | (26,607) | (29,839) | (29,935) | (33,424) | | Interest Expense | 44 | 69 | 53 | 29 | | Income Before Tax | (26,651) | (29,908) | (29,988) | (33,453) | | Income Tax Expense |
-
| (27) | (66) | (89) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (26,651) | (29,881) | (29,922) | (33,364) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (26,651) | (29,881) | (29,922) | (33,364) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($26,651) | ($29,881) | ($29,922) | ($33,364) |
|
1.23% Nasdaq 
Income Statement
